Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Interchangeable Biosimilars: FDA Clarifies US Reference Not Mandatory For Studies

Oct 27 2017

• By Derrick Gingery

Twin girls are exercising on a lake shore, sprinkling water.

Related Content

Biosimilar Interchangeability May Be Losing Luster As Approval Goal

Sep 13 2016

Sandoz's Multi-Switch Biosimilar Trials: A View To Interchangeability?

Jul 22 2016

Humira Biosimilar Interchangeability: The Race Begins

Jul 30 2017

Biosimilar Firms Fight Against 'Whisper Campaign' On Interchangeability

Oct 22 2017

Biosimilars: US FDA Education Campaign Is Non-Committal On Non-Medical Switching

Oct 25 2017

US Comparator Requirement For Interchangeable Biosimilars Would Hurt Industry

Jun 01 2017

Biosimilars: Postmarketing Data Alone Not Enough For Interchangeability

Jan 18 2017

Related Companies

Boehringer Ingelheim GmbH

Novartis AG

Additional Topics

United States Biosimilars FDA Regulation BioPharmaceutical

More from Biosimilars

More from Biosimilars & Generics

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window